Stock Price Quote

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE126.45-6.65 (-5 %)
PREV CLOSE ( ) 133.10
OPEN PRICE ( ) 133.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 766
TODAY'S LOW / HIGH ( )126.45 135.75
52 WK LOW / HIGH ( )5.25 184
NSE130.10-2.95 (-2.22 %)
PREV CLOSE( ) 133.05
OPEN PRICE ( ) 135.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 130.10 (4)
VOLUME 1666
TODAY'S LOW / HIGH( ) 127.10 138.75
52 WK LOW / HIGH ( )4.4 233.55
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Bafna Mahaveer Chand - Chairman - Managing Director
Registered Office

Address Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,
Chennai,
Tamil Nadu-600001

Phone 044- 25267517/25270992

Email cs@bafnapharma.com

Website www.bafnapharma.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, MCX

NEWS

01Aug Bafna Pharmaceuticals informs about vo
Bafna Pharmaceuticals has informed that it has enclosed voting results f..
19Jan Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
24Nov Bafna Pharmaceuticals informs about co
Bafna Pharmaceuticals has informed that Radhakrishnan Dharmarajan has be..
21Jul Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
28May Bafna Pharmaceuticals’ unit gets renew
Bafna Pharmaceuticals’ facility has received renewal approval as per the..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit4.77999999999999-252.04
Gross Profit 4.77999999999999 -252.04
Operating Profit 15.1314.85
Net Sales 151.99424.72

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  14535.90 (0.84%)
M.Cap ( in Cr)30887.77
Alkem Laboratories (BSE)
peergroup  3110.05 (2.51%)
M.Cap ( in Cr)37185.31
Aurobindo Pharma (BSE)
peergroup  998.00 (8.05%)
M.Cap ( in Cr)58476.67
JB Chem & Pharma (BSE)
peergroup  1046.45 (5.34%)
M.Cap ( in Cr)8087.19
Dr. Reddys Lab (BSE)
peergroup  5082.10 (0.96%)
M.Cap ( in Cr)84514.37

Shareholding Pattern

PROMOTERS 92.64%
NON-INSTITUTION 7.36%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 133.1. Its current market capitalisation stands at Rs 299.13 Cr. In the latest quarter, company has reported Gross Sales of Rs. 424.73 Cr and Total Income of Rs.427.28 Cr. The company's management includes Atul Sachdeva, Ravichandran Chitra, Akilapriya Chandrashekar Raju, Palamadi Krishnan Sundaresan, B Kamlesh Kumar, Shanmugam Hemalatha, Bafna Mahaveer Chand.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)